Type 2 diabetes mellitus (T2DM) represents progressive loss of pancreatic β‐cell functional heterogeneity and insulin secretory capacity, frequently coinciding with insulin resistance and metabolic syndrome, thereby elevating morbidity risks of multisystem complications, including chronic kidney disease, hepatic disorders, and CVDs. The gene discussed is INS; the disease is type 2 diabetes mellitus.